Together with Consulting Editor Dr. Alan Buchman, Drs. Arun J. Sanyal and Mohammad Siddiqui have put together a comprehensive issue devoted to fatty liver disease for the gastroenterologist. Expert authors have contributed clinical review articles on the following topics: Burden of disease due to NAFLD; Genetic risk factors and disease modifiers of NASH; How to identify the patient with NASH who will progress to cirrhosis; Similarities and Differences between cirrhosis due to NASH versus other etiologies; Impications of NASH as the etiology of end stage liver disease prior to and after liver transplantation; Why do lifestyle recommendations fail in most patients; Rational nutritional therapeutics for NAFLD; Recruitment and retention strategies in long-term trials for NASH; Managing extrahepatic comorbidities in NAFLD; The current status of noninvasive tools for the assessment of NAFLD; and Pharmacological Treatment strategies for NASH. Readers will come away with the information they need to improve outcomes in patients with fatty liver disease.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. xi 8. Preface - p. xiii 9. Erratum - p. ix 10. Burden of Disease due to Nonalcoholic Fatty Liver Disease - p. 1 11. Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis - p. 25 12. How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis - p. 45 13. Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives - p. 63 14. Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease? - p. 95 15. Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis - p. 105 16. Recruitment and Retention of Patients for Nonalcoholic Steatohepatitis Clinical Trials - p. 123 17. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease - p. 141 18. Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis - p. 151 19. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant - p. 165
No hay muestra disponible
No hay ficha técnica disponible
Together with Consulting Editor Dr. Alan Buchman, Drs. Arun J. Sanyal and Mohammad Siddiqui have put together a comprehensive issue devoted to fatty liver disease for the gastroenterologist. Expert authors have contributed clinical review articles on the following topics: Burden of disease due to NAFLD; Genetic risk factors and disease modifiers of NASH; How to identify the patient with NASH who will progress to cirrhosis; Similarities and Differences between cirrhosis due to NASH versus other etiologies; Impications of NASH as the etiology of end stage liver disease prior to and after liver transplantation; Why do lifestyle recommendations fail in most patients; Rational nutritional therapeutics for NAFLD; Recruitment and retention strategies in long-term trials for NASH; Managing extrahepatic comorbidities in NAFLD; The current status of noninvasive tools for the assessment of NAFLD; and Pharmacological Treatment strategies for NASH. Readers will come away with the information they need to improve outcomes in patients with fatty liver disease.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. viii 7. Foreword - p. xi 8. Preface - p. xiii 9. Erratum - p. ix 10. Burden of Disease due to Nonalcoholic Fatty Liver Disease - p. 1 11. Genetic Risk Factors and Disease Modifiers of Nonalcoholic Steatohepatitis - p. 25 12. How to Identify the Patient with Nonalcoholic Steatohepatitis Who Will Progress to Cirrhosis - p. 45 13. Nutrition and Nonalcoholic Fatty Liver Disease: Current Perspectives - p. 63 14. Why Do Lifestyle Recommendations Fail in Most Patients with Nonalcoholic Fatty Liver Disease? - p. 95 15. Pharmacologic Treatment Strategies for Nonalcoholic Steatohepatitis - p. 105 16. Recruitment and Retention of Patients for Nonalcoholic Steatohepatitis Clinical Trials - p. 123 17. Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease - p. 141 18. Similarities and Differences Between Nonalcoholic Steatohepatitis and Other Causes of Cirrhosis - p. 151 19. Implications of Nonalcoholic Steatohepatitis as the Cause of End-Stage Liver Disease Before and After Liver Transplant - p. 165
No hay muestra disponible
No hay ficha técnica disponible
